Medication Management for Acromegaly

Cheol Ryong KuSouth Korea Speaker Medication Management for AcromegalyPharmacological management of acromegaly plays a central role in patients with persistent disease following surgery; however, treatment strategies vary substantially across countries due to differences in healthcare systems and reimbursement policies. Understanding real-world approaches within specific national frameworks provides valuable insight into optimizing long-term disease control. This lecture aims to present the Korean reimbursement-based treatment algorithm for acromegaly and share institutional clinical outcomes using contemporary medical therapies, including pasireotide, pegvisomant, and lanreotide autogel with extended dosing interval (EDI) strategies. In addition, emerging therapeutic candidates under development at our institution will be briefly introduced.